Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aarti Drugs Limited ( (IN:AARTIDRUGS) ) has shared an update.
Aarti Drugs Limited has announced the scheduling of its 40th Annual General Meeting (AGM) for September 24, 2025, to be conducted via video conferencing. The company has released its Annual Report for the financial year 2024-25, which includes financial statements and instructions for e-voting and AGM attendance. This move reflects the company’s adaptation to digital communication and engagement with stakeholders, ensuring transparency and accessibility.
More about Aarti Drugs Limited
Aarti Drugs Limited operates in the pharmaceutical industry, focusing on the production and distribution of active pharmaceutical ingredients (APIs), formulations, and specialty chemicals. The company is known for its commitment to sustainability and innovation in the healthcare sector.
Average Trading Volume: 33,129
Technical Sentiment Signal: Buy
Current Market Cap: 42.85B INR
Find detailed analytics on AARTIDRUGS stock on TipRanks’ Stock Analysis page.